Article Details
Retrieved on: 2024-09-26 16:25:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche RHHBY announced positive top-line data from a late-stage study of its marketed drug, Gazyva/Gazyvaro (obinutuzumab), to treat patients with ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here